Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Nuclear Medicine"
DOI: 10.1007/s12149-021-01575-x
Abstract: Tumor-induced osteomalacia (TIO) is caused by typically small tumors that secrete fibroblast growth factor 23 (FGF23). As tumor resection is the only effective treatment for TIO, it is important to detect the culprit tumor. We… read more here.
Keywords: dotatoc pet; 68ga dotatoc; dotatoc; tumor induced ... See more keywords
Impressive Response to Tandem Treatment With [90Y]DOTATOC and [177Lu]DOTATOC in Grade 3 Pancreatic Neuroendocrine Carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002116
Abstract: Peptide receptor radionuclide therapy is an effective, well-tolerated, treatment for well-differentiated neuroendocrine tumors, resulting in a significant survival benefit and improvement of quality of life. Very few data are available on peptide receptor radionuclide therapy… read more here.
Keywords: treatment; dotatoc; impressive response; tandem treatment ... See more keywords
Incidental Finding of a Parotid Basal Cell Adenoma With High Tracer Uptake on 68Ga-DOTATOC PET/CT.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000003564
Abstract: ABSTRACT A 67-year-old man was referred to our department to undergo a 68Ga-DOTATOC PET/CT during the systematic follow-up of a small intestine neuroendocrine tumor. PET revealed an incidental focal increased uptake of 68Ga-DOTATOC matching with… read more here.
Keywords: dotatoc pet; 68ga dotatoc; basal cell; dotatoc ... See more keywords
Feasibility of Single Time Point Dosimetry Application in 177Lu-DOTATATE/DOTATOC-treated Pediatric Neuroblastoma.
Sign Up to like & getrecommendations! Published in 2025 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000006029
Abstract: BACKGROUND 177Lu-DOTATATE/DOTATOC peptide receptor radionuclide therapy (PRRT) has demonstrated potential for treating pediatric neuroblastoma (NB), and in clinical practice can be measured dosimetry by multi-time point (MTP) dosimetry. However, the high workload and limited patient… read more here.
Keywords: dotatoc; 177lu dotatate; dotatate; time point ... See more keywords
Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11041052
Abstract: Background: The timing of imaging for 68gallium (68Ga)-PSMA and 68Ga-DOTATOC are stated to be around 60 min post-injection (p.i.). In some lesions, late imaging (3–4 h p.i.) showed advantages. The aim of our evaluation was… read more here.
Keywords: 68ga dotatoc; dotatoc; prostate cancer; 68ga psma ... See more keywords
68Ga-DOTATOC PET/CT in the Localization of Pituitary Tumors in Cushing’s Disease
Sign Up to like & getrecommendations! Published in 2025 at "Endocrinology and Metabolism"
DOI: 10.3803/enm.2024.2249
Abstract: Background This study aimed to determine the value of 68Ga-DOTATOC positron emission tomography/computed tomography (PET/CT) in localizing adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas. Methods In this retrospective cohort study, we enrolled 30 patients with Cushing’s disease… read more here.
Keywords: dotatoc pet; dotatoc; 68ga dotatoc; localization ... See more keywords
Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions
Sign Up to like & getrecommendations! Published in 2018 at "Theranostics"
DOI: 10.7150/thno.24017
Abstract: Reporter gene systems can serve as therapy targets. However, the therapeutic use of reporters has been limited by the challenges of transgene delivery to a majority of cancer cells. This study specifically assesses the efficacy… read more here.
Keywords: somatostatin receptor; 68ga dotatoc; dotatoc; reporter gene ... See more keywords